NanoMech, Inc. and Cameron (NYSE: CAM) announce an agreement to utilize TriboTuff(R) lubricant in some of Cameron’s valves and flow equipment used extensively in the worldwide gas and oil supply chain. This innovation dramatically extends performance, durability and reliability of critical mechanical components. NanoMech’s patent-pending macro-molecular nano-manufactured solution, TriboTuff, reduces friction to near zero for the first time in history, driving performance of machines and vehicles up, while significantly decreasing the amount of fossil fuel used.
The nGlide(R) technology platform product, TriboTuff, is a great example of NanoMech’s patented nano-inspired combinatorial material science it has pioneered in TuffTek(R) coatings that is also revolutionizing the cutting tool manufacturing industry.
http://www.nanomech.biz
Nanometrics Incorporated (NASDAQ:NANO) announced financial results for its second quarter ended June 30, 2012. Revenues for the second quarter of 2012 were $53.2 million, down 4% from $55.5 million in the first quarter and down 17% from $64.4 million in the second quarter of 2011. GAAP gross margin was 46.6%, compared to 45.2% in the prior quarter and 55.7% in the year-ago period. GAAP net income was $4.5 million or $0.19 per diluted share, compared to $1.7 million or $0.07 per diluted share in the prior quarter and $11.1 million or $0.47 per diluted share in the second quarter of 2011. Non-GAAP net income was $3.1 million or $0.13 per diluted share, compared to $2.9 million or $0.12 per diluted share in the prior quarter and $11.3 million or $0.48 per diluted share in the second quarter of 2011.
At June 30, 2012, Nanometrics had $95.8 million in cash, cash equivalents and marketable securities and $161.9 million in working capital. Stockholders’ equity, excluding intangible assets, was $193.8 million, or $8.36 per share based on 23.2 million shares outstanding at quarter end.
Management forecasts a slowdown in industry spending, with total revenues expected to be in the range of $40 to $45 million in the third quarter of 2012. Management expects GAAP gross margin in the range of 44% to 48%, non-GAAP gross margin in the range of 46% to 49%, and operating expenses to increase between $0.4 million and $0.7 million from the second quarter. Management expects third quarter GAAP net earnings in the range of ($0.09) to $0.00 per share and non-GAAP net earnings in the range of ($0.07) to $0.02 per share.
http://www.nanometrics.com
Nanosphere, Inc. (NASDAQ:NSPH) reported financial results for the second quarter ending June 30, 2012. Revenues for the second quarter 2012 were $1.3 million compared to $0.5 million for the same period 2011. Revenue growth was attribu- table to new customer placements of the VerigeneSP System. Net loss for the second quarter of 2012 was $8.4 million, equivalent to the same period in 2011. The Company entered into marketing and distribution agreement in Europe with Thermo Fisher Scientific, and shipped 25 systems in the quarter; 166 cumulative systems placed.
http://www.nanosphere.us
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105